Englewood Health has announced the appointment of Leah Gologorsky to its board of trustees. Gologorsky, an accomplished financial executive with over two decades of experience, is expected to bring valuable expertise in strategy, risk, and operations to the board.
Gologorsky currently serves as the global lead of bank counterparty strategy at Citadel Securities. Her career includes senior leadership positions at major financial institutions, including Bank of America, Santander, Morgan Stanley, and Lehman Brothers, where she focused on financial resource management, capital optimization and regulatory strategy.
Richard Lerner, chairman of the Board of Trustees, expressed his enthusiasm for the new appointment. “Her record of leadership at some of the most respected firms in finance will help guide Englewood Health as we continue to grow and innovate in service to our community,” he said.
Warren Geller, president and CEO of Englewood Health, added that Gologorsky’s commitment will be crucial as the health system expands across northern New Jersey. “We rely on the commitment of individuals like Leah to help us maintain our high standards of care while preparing for the future,” he stated.
As a Bergen County resident, Gologorsky has seen the impact of Englewood Health firsthand. “It is a privilege to join Englewood Health’s Board of Trustees,” she said. “I look forward to drawing on my experience to advance its mission of providing exceptional care.”
